Jason Ryan

Jason Ryan has an estimated net worth of $25 Million. This is based on reported shares across multiple companies, which include Singular Genomics Systems, Inc., GeneDx Holdings Corp., Foundation Medicine, Inc., Magenta Therapeutics, Inc., and SomaLogic, Inc..

2014 was Jason Ryan's most active year for acquiring shares with 17 total transactions. Jason Ryan's most active month to acquire stocks was the month of May. 2014 was Jason Ryan's most active year for disposing of shares, totalling 30 transactions. Jason Ryan's most active month to dispose stocks was the month of May. 2017 saw Jason Ryan paying a total of $1,346,388.80 for 66,960 shares, this is the most they've acquired in one year. In 2018 Jason Ryan cashed out on 167,095 shares for a total of $11,616,223.43, their largest year based on trade value.